Clinical Trial Update: Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ACT-541468 for efficacy and safety in elderly subjects with insomnia disorder has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• ACT-541468

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Insomnia Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-04-24